Peak HumanDatabase
    All Supplements
    Supplement

    NattokinaseNew

    Supplement
    Cardiovascular Support
    4/10 Evidence

    A fibrinolytic enzyme purified from natto (fermented soybean), taken for blood pressure and cardiovascular risk support, with human evidence that is modest, short-term, and surrogate-endpoint only.

    Mechanism of Action

    Nattokinase (subtilisin NAT) degrades fibrin directly and may enhance endogenous fibrinolysis by increasing plasmin activity and tPA activity, while also reducing fibrinogen and factor VII/VIII in small human studies; a possible ACE-inhibitory effect has been proposed for its blood-pressure action.

    Dosing Protocol

    Recommended

    2000FU (fibrinolytic units) per day

    Standard starting dose based on research

    Therapeutic Range

    2000

    Minimum

    to

    4000

    Maximum

    FU (fibrinolytic units) per day

    Empty stomach, once daily (morning or bedtime); stop 2 weeks before elective surgery

    Cycling Protocol

    No formal cycling protocol; long-term (>6 months) human safety data are limited, so periodic reassessment of blood pressure and bleeding history is reasonable

    Dosages are general guidelines. Individual requirements vary based on body weight, health status, and specific goals. Start with lower doses and adjust based on response.

    Benefits

    Primary Benefits

    • Modest blood pressure reduction
    • Support for healthy fibrinolysis / clotting balance
    • Cardiovascular risk-factor support

    Secondary Benefits

    Possible effect on carotid intima-media thickness (limited, single-group data)
    Possible fibrinogen lowering

    Safety Information

    Contraindications

    Do not use if any of the following apply:

    • •Bleeding disorders
    • •Active or recent hemorrhagic stroke or GI bleeding
    • •Planned surgery within 2 weeks
    • •Pregnancy and breastfeeding (insufficient safety data)
    • •Soy or natto allergy

    Drug/Supplement Interactions

    May interact with the following. Consult a healthcare provider before combining:

    Anticoagulants and antiplatelets (warfarin, DOACs, aspirin, clopidogrel) — additive bleeding risk
    Other fibrinolytic/antithrombotic supplements (fish oil at high dose, ginkgo, high-dose vitamin E, garlic)
    Antihypertensive medications — additive blood-pressure lowering
    Vitamin K-containing products can interfere with warfarin control — confirm the product is K2-free if on warfarin

    Potential Side Effects

    Some users may experience:

    Mild GI upset
    Headache
    Allergic reaction in soy-sensitive individuals
    Theoretical increased bleeding or bruising

    This is not a complete list of interactions or side effects. Individual responses vary. Always start with the lowest effective dose and monitor your response. Report any adverse effects to your healthcare provider.

    Quality Markers

    Look for these specific quality indicators when sourcing this compound:

    • Standardized in FU (activity), not just mg — look for 2,000 FU per serving
    • Vitamin K2-free (purified) if on anticoagulants
    • Third-party tested (NSF/USP/Informed Choice)
    • Labeled as nattokinase enzyme, not whole natto powder

    Trusted Certifications

    NSF Certified
    USP Verified
    GMP Certified
    ConsumerLab Approved

    Note: Supplement quality varies dramatically between brands. Cheap supplements often contain fillers, incorrect doses, or contaminants. Investing in quality products from reputable manufacturers is essential for safety and efficacy.

    Evidence Profile

    Evidence Score

    4/10

    Emerging/Anecdotal

    Limited clinical data, primarily mechanistic studies or user reports

    Classification:
    Emerging/Moderate — a 2023 systematic review and meta-analysis of 6 RCTs (n=546) found significant reductions in systolic (about -3.5 mmHg) and diastolic (about -2.3 mmHg) blood pressure, but trials are short, small, and use widely varying doses (1,200-8,000 FU/day); lipid results are mixed, and no trial has shown reduced heart attack, stroke, or mortality, so the evidence supports a modest surrogate-marker effect rather than proven cardiovascular prevention Evidence

    Evidence Scale

    8-10

    Strong

    5-7

    Moderate

    1-4

    Emerging

    PHS
    671
    / 1000
    T3
    Longevity Operator

    Sample member

    Longevity Operator

    The Peak Human Score · PHS v1

    One number for your longevity journey.

    FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.

    • Metabolic
    • Hormonal
    • Cardiovascular
    • Brain / Cognitive
    • Sleep
    • Musculoskeletal
    • Gut
    • Immunity / Inflammation
    See your Peak Human Score How it works